Nature, Published online: 21 January 2026; doi:10.1038/d41586-026-00094-x
Dopamine signals have long been a target for ADHD treatments. Now, researchers are learning how the neurotransmitter influences the condition.Nature, Published online: 21 January 2026; doi:10.1038/d41586-026-00094-x
Dopamine signals have long been a target for ADHD treatments. Now, researchers are learning how the neurotransmitter influences the condition.